Cogswell Mary E, Looker Anne C, Pfeiffer Christine M, Cook James D, Lacher David A, Beard John L, Lynch Sean R, Grummer-Strawn Laurence M
Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA, USA.
Am J Clin Nutr. 2009 May;89(5):1334-42. doi: 10.3945/ajcn.2008.27151. Epub 2009 Apr 8.
A new index to determine body iron promises a simpler approach to monitoring iron deficiency (ID) prevalence.
Our objective was to compare ID defined as body iron <0 mg/kg and calculated from the log ratio of transferrin receptor to ferritin (the body iron model) to ID defined as >/=2 of 3 abnormal concentrations in ferritin, transferrin saturation, or erythrocyte protoporphyrin (the ferritin model).
We used measures of iron status and inflammation from 486 children aged 1-2 y, 848 children aged 3-5 y, and 3742 nonpregnant females aged 12-49 y from the National Health and Nutrition Examination Survey 2003-2006.
ID prevalences (+/-SE) based on the body iron model in children (1-2 and 3-5 y) and in females (12-19 and 20-49 y) were 14.4 +/- 1.9%, 3.7 +/- 0.8%, 9.3 +/- 1.0%, and 9.2 +/- 1.6%, respectively. ID prevalences based on the ferritin model in children (3-5 y) and females (12-19 and 20-49 y) were 4.5 +/- 0.9%, 15.6 +/- 1.2%, and 15.7 +/- 0.8%, respectively. The kappa statistics for agreement between the 2 models were 0.5-0.7. Among females (12-49 y) the positive predictive values of ID based on the body iron model and the ferritin model for identifying anemia were 43 +/- 3% and 30 +/- 2%, respectively, whereas negative predictive values did not differ. C-reactive protein was elevated in 28.8 +/- 3.1% of females with ID by the ferritin model but not by the body iron model and in 0% of persons with ID by the body iron model but not by the ferritin model.
The agreement between the 2 indexes was fair to good. Among females, the body iron model produced lower estimates of ID prevalence, better predicted anemia, and appeared to be less affected by inflammation than the ferritin model.
一种用于确定机体铁含量的新指标有望为监测缺铁(ID)患病率提供更简便的方法。
我们的目的是比较将ID定义为机体铁含量<0 mg/kg并根据转铁蛋白受体与铁蛋白的对数比值计算得出(机体铁模型),与将ID定义为铁蛋白、转铁蛋白饱和度或红细胞原卟啉中3项异常浓度中≥2项(铁蛋白模型)的情况。
我们使用了2003 - 2006年美国国家健康与营养检查调查中486名1 - 2岁儿童、848名3 - 5岁儿童以及3742名12 - 49岁非妊娠女性的铁状态和炎症指标。
基于机体铁模型,儿童(1 - 2岁和3 - 5岁)及女性(12 - 19岁和20 - 49岁)的ID患病率(±标准误)分别为14.4±1.9%、3.7±0.8%、9.3±1.0%和9.2±1.6%。基于铁蛋白模型,儿童(3 - 5岁)及女性(12 - 19岁和20 - 49岁)的ID患病率分别为4.5±0.9%、15.6±1.2%和15.7±0.8%。两种模型之间一致性的kappa统计量为0.5 - 0.7。在女性(12 - 49岁)中,基于机体铁模型和铁蛋白模型诊断ID的贫血阳性预测值分别为43±3%和30±2%,而阴性预测值无差异。铁蛋白模型诊断为ID的女性中28.8±3.1%的C反应蛋白升高,而机体铁模型诊断为ID的女性中C反应蛋白升高者为0%;机体铁模型诊断为ID但铁蛋白模型未诊断为ID的人群中C反应蛋白升高者也为0%。
两种指标之间的一致性为中等至良好。在女性中,机体铁模型对ID患病率的估计较低,对贫血的预测较好,且似乎比铁蛋白模型受炎症影响更小。